BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

SHENKMAN CAPITAL MANAGEMENT INC's Holding History (CIK: 0001275228)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 10,707,000 Value ($000) $12,418 Avg Close — Range —
Q3 2025
Shares 6,740,000 Value ($000) $6,827 Avg Close — Range —